Trump Raises Concerns with Remarks on Widely Used Medication

Trump sparks major concern as he takes aim at very common medication

There have also been a number of healthcare experts in Washington who have voiced their opposition to the new order issued by the White House.

According to a controversial new executive order, Donald Trump has set his sights on mental drugs, and healthcare professionals all around the United States are getting ready to make significant changes to the regulatory processes that are in place when it comes to children.

Earlier this week, the Republican leader, who is 78 years old, signed a policy issued by the White House that announced the launch of a new campaign that will be known as the “Make America Healthy Again Commission.”

The newly established commission will concentrate on the health of American children, with a particular emphasis on mental health and mental illness. It will be chaired by Robert F. Kennedy Jr., who is the Secretary of Health and Human Services for the United States of America.

President Trump’s fresh approach to the health of children

The new order that President Trump issued called for “dramatically lowering chronic disease rates and ending childhood chronic disease.” This will be accomplished by “assessing the threat that potential over-utilization of medication,” “certain chemicals,” and “certain other exposures” bring to children.

In addition to this, the policy commits to “evaluating the prevalence of and threat posed by the prescription of selective serotonin reuptake inhibitors, antipsychotics, mood stabilizers, stimulants, and weight-loss drugs.”

An initial report concerning prescriptions of these kinds of pharmaceuticals is required to be submitted by the newly formed commission within one hundred days of the date on which the decree was issued. And then, eighty days after that, the commission is obligated to present a strategy about measures to improve the overall health of children, along with recommendations for the federal government.

Is there a reason for the concern of healthcare professionals?

Concern has been raised in the medical community as a result of the new policy’s indication that mental health medication, which is frequently life-saving in cases involving depression and anxiety, poses a hazard to children. This is despite the fact that President Trump’s focus on children’s health may be somewhat desirable.

Drugs that are routinely prescribed, such as SSRIs, antipsychotics, and stimulants, can, just like any other prescription, have the potential to cause physical adverse effects. However, these medications are also extremely important for a large number of young people who are battling with mental health issues.

According to the report, there are 8.4 million youngsters who are affected by attention-deficit/hyperactivity disorder (ADHD) and attention-deficit/hyperactivity disorder (ADHD).

In an interview with The Seattle Times, Dr. Lelach Rave, who serves as the interim executive director of the Washington Chapter of the American Academy of Pediatrics, has expressed his thoughts on the matter since the news was first reported on Wednesday nineteenth February.

“Any parent who has a child who is struggling with depression or anxiety or psychosis, it’s a scary place to be,” she further pointed out. “And there’s a lot of harm that goes with having untreated illness.”

Continuing, the renowned physician stated, “It is not that you minimize the dangers associated with medications because they are also real; however, there is a genuine risk associated with disease.”

According to the journal, a number of other Washington physicians have expressed their agreement with the idea that monitoring prescriptions is a reasonable practice. However, they are of the opinion that a federal requirement may potentially cause a rift between physicians and their fellow medical professionals.

During her forthright discussion of the consequences for mental health, Summer Starr, who is now serving as the interim head of the National Alliance on Mental Illness in Washington, also articulated her worries.

“You’d never deny someone cancer treatment,” she said at the beginning. It is not the same level of stigma that is associated with that. We are working hard to reduce the stigma associated with mental health, and this makes our efforts even more difficult.

In addition, she stated that depriving children and adolescents the opportunity to receive first treatment for mental health and mental illness could have a negative impact on their recovery in the future.

“I do know that the earlier people are able to get the support that is needed for mental health recovery, the better that process is for them.”